MedTech stocks continue to feel pressure from glucagon-like peptide-1 (GLP-1) drugs for obesity, based primarily on speculation, and despite strong third-quarter performances from many firms in this sector
A new Gallup poll shows 11% of adults say they are currently using one, a dramatic increase from just two years ago, when 3% said they were using them
Investigating visceral lipolysis or NAFLD : tesamorelin
Experts say that regular screening and a healthy lifestyle remain important preventive measures
Cellular GSH (cytosol, mitochondria, endoplasmic reticulum, nucleus
Some research suggests that diet modifications might help alleviate gut issues and improve behavioral outcomes, though obesity and nutrient deficiencies remain concerns